The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
There were no significant differences in adherence and viral suppression rates between people in relationships and those who are single in Brazil, but the type of regime and pill quantities predict better outcomes.
The number of people living with HIV experiencing more than one non-communicable disease (NCD) increased as they got older, with metabolic diseases being the biggest contributor.
Results from Latin America’s first PrEP demonstration project reveal that it is both feasible and effective as an HIV prevention method in the region. Will Brazil’s example pave the way for the rest of the region?
New study provides insights into the factors that influence treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions.
A new low-cost, low-tech method for predicting an adult’s risk of developing tuberculosis (TB) could represent a major step forward for TB prevention.
Concerns have been raised about the shortage of antiretroviral drugs available for people living with HIV in Venezuela, which is in the midst of a mounting health crisis.
Peru is the latest country to approve the use of the antiretroviral drug, Truvada, as pre-exposure prohpylaxis (PrEP) to prevent HIV among people at a high risk of infection.
The World Health Organisation (WHO) has confirmed that Cuba is officially the first country to eliminate mother to child transmission of HIV (MTCT). Cuba has been working with WHO and the Pan American Health Organisation (PAHO) since 2010 as part of a regional programme to eliminate both MTCT and syphilis. Elimination in this sense means ‘a reduction of transmission to such a low level that it no longer constitutes a public health problem.’
People living with HIV in Peru have demanded the Minister of Health, Aníbal Velásquez Valdivia, to declare the need for antiretroviral medication a national interest, and to lift the monopoly on medication, making it possible to buy generic treatment at a much lower price. Currently the US pharmaceutical company Brystol-Myers-Squibb has a government monopoly on the provision of the antiretroviral treatment Atazanavir, meaning the government is unable to buy any other treatment brand.
The number of babies born with HIV in Latin America and the Caribbean has decreased by 78 percent – from 10,700 in 2001, to 2,324 in 2013 – according to a new report by the Pan American Health Organization/World Health Organization (PAHO/WHO), and the United Nations Children's Fund (UNICEF). The report entitled, Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in the Americas, documents progress made towards the 2015 goals of eliminating mother-to-child transmission (MTCT) of HIV and congenital syphilis in the region.